JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB266455

Human CCNL2 knockout HEK-293T cell line

Be the first to review this product! 리뷰 제출

|

(0 출판물)

CCNL2 KO cell line available to order. KO validated. Free of charge wild type control available. Knockout achieved by using CRISPR/Cas9, Homozygous: 1 bp deletion in exon 1. To order both knockout and wild-type control cells: select '2 x 1000000 Cells/vial'. To order only knockout cells: select '1000000 Cells/vial'.
1 이미지
Sanger Sequencing - Human CCNL2 knockout HEK-293T cell line (AB266455)
  • Sanger seq

Unknown

Sanger Sequencing - Human CCNL2 knockout HEK-293T cell line (AB266455)

Homozygous : 1 bp deletion in exon 1

주요 정보

세포 유형

HEK-293T

Species or organism

Human

조직

Kidney

제형

Liquid

form

Knockout 검증

Sanger Sequencing

Mutation 정보

Knockout achieved by using CRISPR/Cas9, Homozygous: 1 bp deletion in exon 1

제품 세부 정보

We will provide viable cells that proliferate on revival.

This product is subject to limited use licenses from The Broad Institute and ERS Genomics Limited, and is developed with patented technology. For full details of the limited use licenses and relevant patents please refer to our limited use license and patent pages.

제품 구성

{ "values": { "2x1000000Cellsvial": { "sellingSize": "2 x 1000000 Cells/vial", "publicAssetCode":"ab266455-2x1000000Cells_vial", "assetComponentDetails": [ { "size":"1 x 1000000 Cells/vial", "name":"ab255449 Human wild-type HEK-293T cell line", "number":"AB266455-CMP02" }, { "size":"1 x 1000000 Cells/vial", "name":"ab266455 Human CCNL2 knockout HEK-293T cell line", "number":"AB266455-CMP01" } ] }, "2x1000000Cellsvial": { "sellingSize": "2 x 1000000 Cells/vial", "publicAssetCode":"ab266455-2x1000000Cells_vial", "assetComponentDetails": [ { "size":"1 x 1000000 Cells/vial", "name":"ab255449 Human wild-type HEK-293T cell line", "number":"AB266455-CMP02" }, { "size":"1 x 1000000 Cells/vial", "name":"ab266455 Human CCNL2 knockout HEK-293T cell line", "number":"AB266455-CMP01" } ] }, "1000000Cellsvial": { "sellingSize": "1000000 Cells/vial", "publicAssetCode":"ab266455-1000000Cells_vial", "assetComponentDetails": [ { "size":"1 x 1000000 Cells/vial", "name":"ab266455 Human CCNL2 knockout HEK-293T cell line", "number":"AB266455-CMP01" } ] }, "1000000Cellsvial": { "sellingSize": "1000000 Cells/vial", "publicAssetCode":"ab266455-1000000Cells_vial", "assetComponentDetails": [ { "size":"1 x 1000000 Cells/vial", "name":"ab266455 Human CCNL2 knockout HEK-293T cell line", "number":"AB266455-CMP01", "productcode":"" } ] } } }

특성 및 보관 정보

유전자명
CCNL2
유전자 편집 종류
Knockout
유전자 편집 방식
CRISPR technology
Knockout 검증
Sanger Sequencing
Zygosity
Homozygous
배송 시 보관 조건
Dry Ice
적절한 단기 보관 조건
-196°C
적절한 장기 보관 조건
-196°C

추가 정보

This supplementary information is collated from multiple sources and compiled automatically.

CCNL2 also known as Cyclin L2 is a protein that plays a role in the regulation of transcription. This protein weighs approximately 59 kDa and contains conserved cyclin domains which aid in its function. It is mainly expressed in tissues like the brain liver and muscle where it performs various regulatory tasks. By interacting with certain kinases CCNL2 helps control the cell cycle's progression particularly during transitions between phases.
Biological function summary

Cyclin L2 modulates transcription processes by associating with splicing factors and RNA polymerase II. It is a part of the spliceosomal complex which influences mRNA processing by ensuring proper splicing of pre-mRNA. This regulation is important for generating diverse and functionally appropriate mRNA transcripts which influences cellular outcome and function. CCNL2's capability to bind with cdk kinases further enhances its role in managing transcription and cell cycle checkpoints within cells.

Pathways

CCNL2 is involved in significant cellular processes such as the cell cycle and mRNA processing pathways. A notable pathway includes the RNA splicing pathway where Cyclin L2 plays a role alongside proteins like cdk kinases which phosphorylate the C-terminal domain to facilitate splicing. Additionally it contributes to the regulation of the cell cycle coordinating with proteins such as cyclin-dependent kinases (CDK) to ensure proper cell cycle progression and division.

Cyclin L2 has associations with cancer and neurological disorders. Abnormal expression or malfunction of CCNL2 can contribute to tumorigenesis potentially through disrupted transcriptional and cell cycle control. In neurological disorders deviations from normal CCNL2 expression levels may impact neuron function and communication. Connections exist between CCNL2 and other proteins implicated in these conditions such as cyclin-dependent kinases which have roles in maintaining cellular homeostasis under normal and disease states.

품질 관리

STR analysis

CSF1PO, D13S317, D7S820, D5S818, TH01, D16S539, TPOX

Cell culture

Biosafety level

EU: 2 US: 2

Adherent/suspension

Adherent

Gender

Female

초기 취급 지침

Upon arrival, the vial should be stored in liquid nitrogen vapor phase and not at -80°C. Storage at -80°C may result in loss of viability. <p>1. Thaw the vial in 37°C water bath for approximately 1-2 minutes.<br>2. Transfer the cell suspension (0.8 mL) to a 15 mL/50 mL conical sterile polypropylene centrifuge tube containing 8.4 mL pre-warmed culture medium, wash vial with an additional 0.8 mL culture medium (total volume 10 mL) to collect remaining cells, and centrifuge at 201 x g (rcf) for 5 minutes at room temperature. 10 mL represents minimum recommended dilution. 20 mL represents maximum recommended dilution.<br>3. Resuspend the cell pellet in 5 mL pre-warmed culture medium and count using a haemocytometer or alternative cell counting method seed all remaining cells into a T25.<br>4. Incubate the culture at 37°C incubator with 5% CO<sub>2</sub>. Check the culture one day after revival and continue to check until 80% confluent. Media change can be given if needed.<br>5. Once confluent passage into an appropriate flask at a density of 2x10<sup>4</sup> cells/cm<sup>2</sup>. Seeding density is given as a guide only and should be scaled to align with individual lab schedules. Cultures should be monitored daily.</p>

Subculture 가이드라인
  • All seeding densities should be based on cell counts gained by established methods.
  • A guide seeding density of 2x104 cells/cm2 is recommended.
  • Cells should be passaged when they have achieved 80-90% confluence.
배양 배지

DMEM (High Glucose) + 10% FBS

동결보존 배지

Cell Freezing Medium-DMSO Serum free media, contains 8.7% DMSO in MEM supplemented with methyl cellulose.

제품 프로토콜

Product promise

저희는 고품질 시약으로 고객님의 연구를 서포트하고자 최선을 다하고 있으며, 모든 단계에서 함께 하겠습니다. 만약 제품이 기대한 성능을 보이지 않을 경우에도 Product Promise로 보호받으실 수 있습니다.
자세한 내용은 이용 약관을 확인해 주세요.

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com